Search Results - "Pariser DM"

Effectiveness, Safety, and Health-Related Quality of Life in Moderate-to-Severe Atopic Dermatitis Treated with Lebrikizumab: A 16-Week Nationwide Retrospective Cohort Study.

Authors: Avallone, Gianluca Bombelli, Andrea Gargiulo, Luigi et al.

Source: Dermatology & Therapy. Dec2025, Vol. 15 Issue 12, p3671-3688. 18p.

Risk of serious infection with JAK inhibitors in immune-mediated inflammatory skin diseases: a meta-analysis of randomized clinical trials.

Authors: Su, Xinhong Ou, Yushan Ruan, Shifan et al.

Source: Journal of Dermatological Treatment. Dec2025, Vol. 36 Issue 1, p1-8. 8p.

Long-Term Safety and Efficacy of Roflumilast Foam 0.3% in Patients with Seborrheic Dermatitis: A Phase II, Open-Label Trial of up to 52 Weeks.

Authors: Alexis AF Bukhalo M Cook-Bolden FE et al.

Source: American journal of clinical dermatology [Am J Clin Dermatol] 2026 Jan; Vol. 27 (1), pp. 189-198. Date of Electronic Publication: 2025 Nov 01.

Publication Type: Journal Article; Clinical Trial, Phase II; Multicenter Study

Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 100895290 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1888 (Electronic) Linking ISSN: 11750561 NLM ISO Abbreviation: Am J Clin Dermatol Subsets: MEDLINE

A real-world study to assess the disease control of moderate to severe atopic dermatitis in patients receiving dupilumab therapy, with atopic dermatitis control tool in Gulf countries.

Authors: Alfalasi, Amani Ameen, Ahmed Al Lafi, Atlal et al.

Source: Journal of Dermatological Treatment. Dec2025, Vol. 36 Issue 1, p1-9. 9p.

Real-World Characteristics, Treatment Patterns, and Outcomes in Adult Patients Receiving Abrocitinib for Atopic Dermatitis in China: Interim Analysis from the AHEAD Registry.

Authors: Zhang, Li Zhou, Naihui Wu, Zhouwei et al.

Source: Dermatology & Therapy. Mar2026, Vol. 16 Issue 3, p1617-1634. 18p.

Evaluation of Outcomes of Dupilumab Therapy in Patients with Atopic Dermatitis – A Single-Center Retrospective Longitudinal Study.

Authors: Miniello, Andrea Pugliese, Francesco Pepe, Ilaria et al.

Source: Indian Journal of Dermatology. May/Jun2026, Vol. 71 Issue 3, p185-190. 6p.

Efficacy and safety of newer biologic therapies in psoriasis treatment: A systematic review and meta-analysis.

Authors: Almutairi, Hadeel R. Althobaiti, Hanouf A. Neazy, Faris A. et al.

Source: Saudi Journal for Health Sciences. Sep-Dec2025, Vol. 14 Issue 3, p239-246. 8p.

Subjects: Psoriasis, Biotherapy, Safety, Treatment effectiveness, Tumor necrosis factors, Interleukin-17, Critical analysis

Author Index 2018.

Source: Australasian Journal of Dermatology. May2018 Supplement S1, Vol. 59, p130-134. 5p.

New topical molecular targeted therapies for atopic dermatitis in children: A systematic review and meta‐analysis.

Authors: Murai, Hiroki Kawamoto, Norio Arima, Tomoyuki et al.

Source: Pediatric Allergy & Immunology. Jun2025, Vol. 36 Issue 6, p1-12. 12p.

The enduring impact of the American Dermatological Association on US dermatology.

Authors: Helm TN Paller AS Pariser DM

Source: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2026 Jan; Vol. 94 (1), pp. 390-392. Date of Electronic Publication: 2025 Sep 02.

Publication Type: Editorial

Journal Info: Publisher: Mosby Country of Publication: United States NLM ID: 7907132 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6787 (Electronic) Linking ISSN: 01909622 NLM ISO Abbreviation: J Am Acad Dermatol Subsets: MEDLINE; In Process

Red light photodynamic therapy with 10% aminolevulinic acid gel showed efficacy for treatment of superficial basal cell carcinoma in a randomized, vehicle controlled, double-blind, multicenter phase III study.

Authors: Schlesinger T Chapman MS Tu JH et al.

Source: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2025 Dec; Vol. 93 (6), pp. 1489-1498. Date of Electronic Publication: 2025 Aug 20.

Publication Type: Journal Article; Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase III; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Mosby Country of Publication: United States NLM ID: 7907132 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6787 (Electronic) Linking ISSN: 01909622 NLM ISO Abbreviation: J Am Acad Dermatol Subsets: MEDLINE

Lebrikizumab Improves Clinical Manifestations, Symptoms, and Quality of Life in Patients with Moderate-to-Severe Atopic Dermatitis Previously Treated with Dupilumab: Results from the ADapt Study.

Authors: Silverberg, Jonathan I. Ackerman, Lindsay Bagel, Jerry et al.

Source: Dermatology & Therapy. Feb2026, Vol. 16 Issue 2, p1309-1330. 22p.

Pharmacokinetic profile data of glycopyrronium bromide 1% cream beyond 2 weeks are important: reply from the authors.

Authors: Abels C Soeberdt M Kilic A et al.

Source: The British journal of dermatology [Br J Dermatol] 2021 Aug; Vol. 185 (2), pp. 468-469. Date of Electronic Publication: 2021 Jun 01.

Publication Type: Letter; Comment

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 0004041 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2133 (Electronic) Linking ISSN: 00070963 NLM ISO Abbreviation: Br J Dermatol Subsets: MEDLINE

A bioelectronic device for electric field treatment of wounds reduces inflammation in an in vivo mouse model.

Authors: Hernandez, Cristian O. Hsieh, Hao-Chieh Zhu, Kan et al.

Source: PLoS ONE. 6/14/2024, Vol. 19 Issue 6, p1-12. 12p.

Atypical Migrating Nummular Retinal Lesions in an Immunosuppressed Patient With Whipple Disease.

Authors: Shah, Shivesh Velcani, Frida Levine, Emily S. et al.

Source: ACG Case Reports Journal. Jan2026, Vol. 13 Issue 1, p1-5. 5p.

Prevalence and Trends in Systemic Treatment for Pediatric Psoriasis in the USA between 2015 and 2021.

Authors: Ramond, Anna Rosario-Jansen, Theresa Yang, Xinyu et al.

Source: Dermatology & Therapy. Dec2025, Vol. 15 Issue 12, p3765-3776. 12p.

The ChinaSTAD Chinese Registry in Patients with Moderate-To-Severe Atopic Dermatitis Not Controlled by Topical Therapy: Baseline Characteristics, Disease Burden and Treatment.

Authors: Liu, Ping Lin, Bingjiang Shen, Yanna et al.

Source: Dermatology & Therapy. Nov2025, Vol. 15 Issue 11, p3377-3389. 13p.

Efficacy and Safety of Sarecycline in Chinese Patients with Moderate-to-Severe Acne Vulgaris: Randomized Phase 3 Clinical Trial with Open-Label Follow-Up.

Authors: Zhang, Jianzhong He, Li Chen, Xue et al.

Source: Dermatology & Therapy. Nov2025, Vol. 15 Issue 11, p3285-3300. 16p.

Indian expert Delphi consensus on the diagnosis and management of flares of generalised pustular psoriasis.

Authors: Aithal, Vijay Venkatraj Bhat, Ramesh Das, Sudip et al.

Source: Indian Journal of Dermatology, Venereology & Leprology. May/Jun2025, Vol. 91 Issue 3, p1-8. 8p.

The risk of malignancy in patients with psoriasis treated with long-term tumour necrosis factor-alpha inhibitors: a systematic review and meta-analysis.

Authors: Wu, Wen-Ting Chiang, Ming-Che Huang, Yu-Chen

Source: Clinical & Experimental Dermatology. May2025, Vol. 50 Issue 5, p968-980. 13p.